NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
NeOnc’s (NASDAQ: NTHI) investigational brain-cancer programs, NEO100 and NEO212, have upcoming FDA catalysts
NeOnc’s (NASDAQ: NTHI) investigational brain-cancer programs, NEO100 and NEO212, have upcoming FDA catalysts